Merck & Co., Inc.
Market cap $323.7B
$131.07
MRK
$131.07
+0.45% today
Buy with €1M virtual cash · No real money
Merck & Co., Inc. (MRK) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates MRK a Buy, with the stock up 56% over the past year. You can practice trading MRK risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$323.7B
Volume
6.2M
52-wk High
$131.74
52-wk Low
$76.66
Day High
$131.71
Day Low
$130.24
P/E (TTM)
36.82
Revenue (TTM)
$65.8B
EPS (TTM)
$3.56
Performance
1M
+8.7%
6M
+20.0%
1Y
+56.1%
Invest signal · MRK
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
MRK overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev -0.7%Revenue
$16BEPS (diluted)
$-1.72 per shareLatest MRK news
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
GlobeNewswire Inc. · 5h ago
If I Were Starting My Portfolio From Scratch Today, This Is the First ETF I'd Buy
The Motley Fool · 16h ago
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
The Motley Fool · 3d ago
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?
The Motley Fool · 4d ago
Want Income for Life? Here Are 3 Stocks to Buy Now and Never Sell.
The Motley Fool · 4d ago
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus.
Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Employees
75,000
30-Day Win Rate · MRK
14 days
9 days
Last 23 sessions
How to practice trading MRK
- 1
Use the MRK buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top MRK traders on Invest
Full leaderboardFrequently asked questions
Is MRK a good stock to buy right now?
As of July 27, 2026, Invest's signal rates MRK a Buy, based on its price trend, valuation, and fundamentals (P/E around 36.8), with the stock up 56% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading MRK risk-free first.
What is Merck & Co., Inc.'s (MRK) market cap?
Merck & Co., Inc. has a market capitalization of approximately $323.7B, on trailing-twelve-month revenue of about $65.8B.
How has MRK stock performed?
MRK is up 56% over the past year and up 20% over six months. Its 52-week range runs roughly from $76.66 to $131.74. Past performance doesn't predict future results.
How can I practice trading MRK for free?
On Invest you get €1,000,000 in virtual cash and can buy MRK at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare MRK with peers